10+ hour, 39+ min ago   (297+ words) Minimal residual disease, or MRD, testing can offer psychological comfort to patients with breast cancer and survivors as well as insight into potential treatment strategies for care providers, as an ... Minimal residual disease, or MRD, testing can offer psychological comfort…...

2+ day, 13+ hour ago   (424+ words) Adding Ibrance to maintenance therapy extends the time some patients with metastatic breast cancer live without their disease progressing. Researchers from the Dana-Farber Cancer Institute and international research groups have published data in The New England Journal of Medicine showing…...

1+ week, 5+ day ago   (479+ words) The U.S. Food and Drug Administration (FDA) has accepted a new drug application for gedatolisib for the treatment of patients with hormone receptor-positive (HR+), human epidermal growth factor ... The U.S. Food and Drug Administration (FDA) has accepted a new drug application for…...

1+ mon, 1+ week ago   (527+ words) Learn how diet and exercise impact breast cancer risk, while getting authoritative guidelines on plate balance, fiber goals, and complex vs. simple carbs. Navigating the landscape of breast cancer prevention and management involves understanding all contributing factors, including those within…...

1+ mon, 1+ week ago   (1002+ words) Clinical trials give patients with metastatic breast cancer access to new treatments, all while being closely monitored and moving the landscape forward. Clinical trials offer patients with metastatic breast cancer access to innovative therapies, closer monitoring, and an opportunity to…...

1+ mon, 1+ week ago   (220+ words) At the 2025 SABCS, researchers presented findings with the potential to meaningfully affect breast cancer treatment and patient care. At the 2025 San Antonio Breast Cancer Symposium (SABCS), researchers presented findings with the potential to meaningfully affect breast cancer treatment and patient…...

1+ mon, 1+ week ago   (384+ words) CURE spoke with a Mayo Clinic expert about the current status of breast cancer vaccines. The landscape of breast cancer research is undergoing a significant shift, moving toward complex, combination strategies designed to overcome the body's own immune suppression. Keith…...

1+ mon, 1+ week ago   (460+ words) When I was diagnosed with breast cancer, I accepted there would be things I couldn't completely control. When I was diagnosed with breast cancer, I accepted there would be things I couldn't completely control: my treatment plan, the shape of…...

1+ mon, 2+ week ago   (427+ words) The FDA has approved Enhertu and Perjeta for the first-line treatment of unresectable or metastatic HER2-positive breast cancer. The U.S. Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab deruxtecan-nxki) in combination with Perjeta (pertuzumab) for the first-line treatment of adults…...

1+ mon, 2+ week ago   (656+ words) Most premenopausal women with early breast cancer accepted GnRHa therapy during chemotherapy to preserve ovarian function, with lower uptake of cryopreservation strategies. Factors influencing ... Most premenopausal women with early breast cancer accepted gonadotropin-releasing hormone agonist (GnRHa) therapy during chemotherapy to…...